Inhibition of novel protein kinase C-epsilon augments TRAIL-induced cell death in A549 lung cancer cells (Q40031192)

16 September 2017

title

Inhibition of novel protein kinase C-epsilon augments TRAIL-induced cell death in A549 lung cancer cells (English)

1 reference

16 September 2017

1 reference

Matthias Felber

1

1 reference

16 September 2017

Jürgen Sonnemann

series ordinal

2

1 reference

16 September 2017

James F Beck

series ordinal

3

1 reference

16 September 2017

publication date

25 December 2007

1 reference

Pathology and Oncology Research

16 September 2017

published in

1 reference

16 September 2017

volume

13

1 reference

16 September 2017

issue

4

1 reference

16 September 2017

page(s)

295-301

1 reference

Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02940308

Differential expression of protein kinase C epsilon protein in lung cancer cell lines by ionising radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02940308

Respiratory syncytial virus infection results in activation of multiple protein kinase C isoforms leading to activation of mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02940308

Expression of tumor necrosis factor receptors in human lung cancer cells and normal lung tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02940308

Selective and nonselective toxicity of TRAIL/Apo2L combined with chemotherapy in human bone tumour cells vs. normal human cells

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Variable expression of protein kinase C epsilon in human melanoma cells regulates sensitivity to TRAIL-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

TRAIL, Fasl and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Integrin signaling links protein kinase Cepsilon to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Exploiting death receptor signaling pathways for tumor therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Promoting apoptosis as a strategy for cancer drug discovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Lung cancer--time to move on from chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

A protective role of PKCepsilon against TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in glioma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Cancer statistics, 2006

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Potential and caveats of TRAIL in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Protein kinase C isozymes as potential targets for anticancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Isoform-selectivity of PKC inhibitors acting at the regulatory and catalytic domain of mammalian PKC-alpha, -betaI, -delta, -eta and -zeta

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

PKCdelta protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-kappaB, activated protein-1 and apoptosis in human lung cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inh

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Comparison of protein kinase C activity and isoform expression in cisplatin‐sensitive and ‐resistant ovarian carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Protein kinase C-epsilon promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Proteolytic activation of protein kinase C-epsilon by caspase-mediated processing and transduction of antiapoptotic signals

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Apo2L/TRAIL and its death and decoy receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Down-regulation of protein kinase Ceta potentiates the cytotoxic effects of exogenous tumor necrosis factor-related apoptosis-inducing ligand in PC-3 prostate cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Apoptosis: a link between cancer genetics and chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18158564

12 December 2020

Identifiers

DOI

10.1007/BF02940308

1 reference

16 September 2017

1 reference